[Weibo Reports Fourth Quarter and Fiscal Year 2016 Financial Results BEIJING, China, February 22, 2017Weibo Corporation (Weibo or the Company) (NASDAQ: WB), a leading social media in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, ]
[Contact: Acorn International, Inc. Compass Investor Relations Ms. Naomi Deng Ms. Elaine Ketchmere, CFA Phone +86-21-5151-2944 Phone: +1-310-528-3031 dengqi@chinadrtv.com Email: Eketchmere@compass-ir.com Email: www.chinadrtv.com www.compassinvestorrelations.com Acorn International Reports Financial R]
[Weibo Reports Fourth Quarter and Fiscal Year 2016 Financial Results BEIJING, China, February 22, 2017Weibo Corporation (Weibo or the Company) (NASDAQ: WB), a leading social media in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, ]
[China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017 3Q17 Added 19,712 New Subscribers 3Q17 Revenue Up 18.6% YOY to RMB200.9 Million ($28.9 Million) 3Q17 Operating Income Reached RMB101.7 Million ($14.6 Million) Conference Call to be Held ]
[THE9 LIMITED Jun Zhu Chairman and Chief Executive Officer The9 Limited Announces Receipt of Nasdaq Notice of Deficiency The Companys management is looking into various options available to regain compliance and maintain its continued listing on The NASDAQ Global Market, and is also considering othe]
[China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017 3Q17 Added 19,712 New Subscribers 3Q17 Revenue Up 18.6% YOY to RMB200.9 Million ($28.9 Million) 3Q17 Operating Income Reached RMB101.7 Million ($14.6 Million) Conference Call to be Held ]
[THE9 LIMITED Jun Zhu Chairman and Chief Executive Officer The9 Limited Announces Receipt of Nasdaq Notice of Deficiency The Companys management is looking into various options available to regain compliance and maintain its continued listing on The NASDAQ Global Market, and is also considering othe]
[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 21, 2017 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Provinc]
[SINA Reports Fourth Quarter and Fiscal Year 2016 Financial Results SHANGHAI, ChinaFebruary 22, 2017 Fourth Quarter 2016 Highlights · · · · · · Fiscal Year 2016 Highlights · · · · · We closed a great year of 2016 with another strong quarter. Our full year revenue exceeded $1 billion, representing ]
[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 21, 2017 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Provinc]
